Partner Value Optimizer™
enables
Pharma and Biotech companies to make more informed and effective
partnering decisions through its creation of real-time business
intelligence
data and analytics. For the first time, alliances can be
proactively managed in concert with their partners with
virtually no additional resources.
PVO™ can assist these
partnerships in understanding these cultural
issues and
allow the
parties to the partnership to create processes to reduce the impact
of these cultural differences.
Further,
PVO™
can assist in measuring value and identifying areas for
improvement in these
pharma-biotech and biotech-biotech alliances in each phase of development.
For Pharma
and Biotech companies, PVO™ enables the ability to maximize the
operational and process effectiveness of drug and product
development against budget and objective timelines from initial
development and clinical trials through demand generation,
marketing and delivery.
Pharma and Biotech (R&D) and Co-Development projects
require collaboration, effective use of capital and effective
communication. Processes, Policies and Personnel must be
aligned to work effectively together towards a common goal.
PVO provides the sophisticated measurement infrastructure required
to optimize development projects between two or more entities so
that project goals and timelines can be more effectively achieved
and resources can be used more effectively.
PVO™ is able
to do this by electronically surveying both companies’ employees
that are involved in the partnership so to determine the
effectiveness of the development’s processes, policies, programs
and personnel at the root perception level and then comparing the
findings against live timelines and budgets.
PVO's
Patent-pending processes enable the ability to proactively
identify and fix issues before they have an opportunity to impact
results. Over time, both companies will gain the knowledge to be
able to drive out operational inefficiencies and costs across
multiple development projects and within multiple development
stages.
PVO™
will continuously extend strategic high-value, long-term benefits
to Pharma and Biotech companies as it
creates a partnership knowledge repository to provide insights
that will allow their today's alliance best practices to be easily
modified as development technologies continue to change.
PVO™ returns a 100% ROI in its first 90 days.
PVO was
developed with one objective in mind – to increase the asset value
contributed by a company’s alliances and partnerships. Since
PVO™ is collecting and analyzing data that has not been collected
before, its intelligence and analytic reporting enables companies to
identify previously unseen opportunities to increase incremental
revenues and to identify previously unseen opportunities to decrease
incremental costs.